Demyelination After Anti-TNF Therapy: Who is at Risk?

J Crohns Colitis. 2020 Dec 2;14(12):1651-1652. doi: 10.1093/ecco-jcc/jjaa144.

Authors

Isabelle Williams¹, Holm H Uhlig^{1

2

3}

Affiliations

¹ Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
² Department of Paediatrics, University of Oxford, Oxford, UK.
³ Oxford NIHR Biomedical Research Centre, Oxford, UK.

PMID: 33026456
DOI: 10.1093/ecco-jcc/jjaa144

No abstract available

Publication types

Editorial
Comment

MeSH terms

Demyelinating Diseases* / chemically induced
Humans
Immunotherapy
Tumor Necrosis Factor Inhibitors*
Tumor Necrosis Factor-alpha

Substances

Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha

Grants and funding

NIHR Oxford Biomedical Research Centre